MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$264,277K
Cash and cash
equivalents
$62,103K
Prepaid expenses and
other current assets
$22,320K
Total current assets
$348,700K
Right of use assets -
operating leases
$370K
Other assets
$156K
Deferred offering costs
$69K
Total assets
$349,295K
Total liabilities and
stockholders' equity
$349,295K
Total stockholders'
equity
$323,980K
Total liabilities
$25,315K
Accumulated deficit
-$447,961K
Accumulated other
comprehensive income (loss)
-$270K
Additional paid-in capital
$772,206K
Total current
liabilities
$24,995K
Operating lease
liabilities, net of current...
$320K
Common stock 0.0001 par
value, 200,000,000...
$5K
Accrued expenses
$16,169K
Accounts payable
$8,727K
Operating lease
liabilities
$99K
Back
Back
Balance Sheet
ArriVent BioPharma, Inc. (AVBP)
ArriVent BioPharma, Inc. (AVBP)
source: myfinsight.com